FATE THERAPEUTICS INC Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2020-07-06: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2020-06-24; Total offering amount $49,999,989.
- 2020-04-21: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2020-04-07; Total offering amount $50,000,024.
- 2016-12-08: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2016-11-23; Total offering amount $56,749,988.
- 2016-08-19: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2016-08-09; Total offering amount $10,290,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2020-07-06 | Rule 506(b) | Equity | 2020-06-24 | $49,999,989 | $49,999,989 | $0 | 1 |
| 2020-04-21 | Rule 506(b) | Equity | 2020-04-07 | $50,000,024 | $50,000,024 | $0 | 1 |
| 2016-12-08 | Rule 506(b) | Equity | 2016-11-23 | $56,749,988 | $56,749,988 | $0 | 21 |
| 2016-08-19 | Rule 506(b) | Equity | 2016-08-09 | $10,290,000 | $10,290,000 | $0 | 4 |
| 2015-05-18 | Rule 506(b) | Equity | 2015-05-07 | $8,000,000 | $8,000,000 | $0 | 1 |
| 2012-08-21 | Rule 506 | Equity | 2012-05-04 | Indefinite | $9,244,679 | Indefinite | 17 |
| 2011-04-20 D/A | Rule 506 | Equity | 2009-11-10 | $35,988,360 | $35,988,360 | $0 | 18 |
| 2009-12-24 D/A | Rule 506 | Equity | 2009-11-10 | $32,488,360 | $32,488,360 | $0 | 16 |
| 2009-11-23 | Rule 506 | Equity | 2009-11-10 | $30,488,360 | $30,488,360 | $0 | 16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |